Which medications and supplements should be avoided in a patient with stage 3 chronic kidney disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Medications and Supplements to Avoid in Stage 3 Chronic Kidney Disease

In stage 3 CKD, you must avoid herbal remedies entirely, use extreme caution with NSAIDs (avoid if GFR <30), temporarily discontinue nephrotoxic drugs during acute illness, and seek medical advice before using any over-the-counter medicines or nutritional protein supplements. 1, 2

Medications That Require Complete Avoidance

Herbal Remedies

  • All herbal remedies should not be used in people with CKD 1, 2
  • This is a strong recommendation (1B) from KDIGO guidelines
  • Specific herbs documented to cause kidney injury include aristolochic acid-containing herbs, St. John's wort, thundergod vine, tribulus, and wormwood 3

High-Risk Medications Requiring Avoidance or Extreme Caution

NSAIDs (Nonsteroidal Anti-Inflammatory Drugs):

  • Avoid in people with GFR <30 ml/min/1.73 m² 2
  • Prolonged therapy is not recommended when GFR <60 ml/min/1.73 m² 2
  • Should not be used in people taking lithium or RAAS blocking agents 2
  • Must be temporarily discontinued during serious intercurrent illness that increases AKI risk 1, 2

Oral Phosphate-Containing Bowel Preparations:

  • Do not use in people with GFR <60 ml/min/1.73 m² (all stage 3 CKD) 2
  • This includes preparations used for colonoscopy

Medications Requiring Temporary Discontinuation During Acute Illness

When you have serious intercurrent illness (infections, dehydration, planned procedures), temporarily discontinue these medications: 1, 2, 1

  • RAAS blockers (ACE inhibitors, ARBs, aldosterone inhibitors, direct renin inhibitors)
  • Diuretics
  • NSAIDs
  • Metformin
  • Lithium
  • Digoxin

This applies to all stage 3 CKD patients (GFR <60 ml/min/1.73 m²) and is critical to prevent acute kidney injury 1, 2

Metformin Management in Stage 3 CKD

Stage 3a (GFR 45-59 ml/min/1.73 m²):

  • Continue metformin 1, 2, 1

Stage 3b (GFR 30-44 ml/min/1.73 m²):

  • Review metformin use carefully 1, 2, 1
  • Consider risk-benefit if GFR is stable 2
  • Suspend during acute illness 2, 4

Over-the-Counter Medicines and Supplements

Critical Practice Point:

  • Adults with CKD must seek medical or pharmacist advice before using over-the-counter medicines or nutritional protein supplements 1, 2, 1
  • This is a strong recommendation (1B) from KDIGO 1

Specific Supplements to Avoid or Use with Caution:

  • Potassium supplements (especially if on RAAS inhibitors) 2
  • High-dose vitamin A, C, and D supplements 2, 3
  • Chromium supplements 3
  • Creatine supplements 3
  • Glucosamine 3

Contrast Agents

Gadolinium-Containing Contrast:

  • Do not use if GFR <15 ml/min/1.73 m² 1
  • If GFR <30 ml/min/1.73 m² (stage 3b), preferentially use macrocyclic chelate preparations 1

Iodinated Radiocontrast:

  • Withdraw potentially nephrotoxic agents before and after procedures 1, 2, 1
  • Ensure adequate hydration with saline 1, 2, 1

Medications Requiring Dose Adjustment (Not Avoidance)

These require dose modification but can still be used: 2, 5

  • Antihypertensives: Beta-blockers (reduce dose by 50% if GFR <30), digoxin (reduce based on plasma levels)
  • Analgesics: Opioids (reduce dose when GFR <60)
  • Antimicrobials: Most require dose adjustment based on specific GFR thresholds
  • Hypoglycemics: Sulfonylureas (avoid glyburide, prefer glipizide), insulin may need dose reduction

Common Pitfalls to Avoid

Do not automatically discontinue RAAS inhibitors when GFR declines:

  • Continue ACE inhibitors or ARBs even when eGFR falls below 30 ml/min/1.73 m² unless specific contraindications arise 6
  • Only reduce dose or discontinue for symptomatic hypotension, uncontrolled hyperkalemia despite treatment, or severe uremic symptoms 6

Monitor closely after starting or adjusting medications:

  • Check GFR, electrolytes, and drug levels regularly for nephrotoxic agents like lithium and calcineurin inhibitors 1, 2, 1
  • Assess within 2-4 weeks of initiating or increasing RAAS inhibitors 6

Do not use combination RAAS therapy:

  • Avoid any combination of ACE inhibitor, ARB, and direct renin inhibitor 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.